Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma
Journal of Cancer · 29.05.2026 · 17 (6) · 1134-1154
DOI: 10.7150/jca.134792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer, erschienen am 29.05.2026. Verfasst von Zheng Shao und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
- School of Medical Technology, Guangdong Medical University, Dongguan, Guangdong, 523808, China.
- Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
- Department of Thoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
Zitieren
APA
Shao, Z., Situ, Y., Lai, B., Xu, Y., Chen, J., Deng, L., Xu, Q., Liang, M., Liang, Z., & Xie, Z. (2026). Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma. Journal of Cancer, 17(6), 1134-1154. https://doi.org/10.7150/jca.134792
Vancouver
Shao Z, Situ Y, Lai B, Xu Y, Chen J, Deng L, et al. Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma. Journal of Cancer. 2026;17(6):1134-1154. doi:10.7150/jca.134792
BibTeX
@article{Shao2026,
author = {Shao, Zheng and Situ, YongLi and Lai, Bairu and Xu, Ying and Chen, Jv and Deng, Li and Xu, QinYing and Liang, Meng and Liang, Zhu and Xie, ZhanQiang},
title = {Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma},
journal = {Journal of Cancer},
year = {2026},
volume = {17},
number = {6},
pages = {1134--1154},
doi = {10.7150/jca.134792}
}
EUVIMED